Can any pharmaceutical people comment on how you are handleing SOP's
that are GLP compliant (21CFR Part 58)? We currently are considering
whether we need to write an individual SOP for each antibody that we
perform by IHC. We have general IHC SOP's in place now and have an
Antibody Specific Protol for each antibody in a Word document. Any
comments are welcome.
Histonet mailing list